Quintiles’ HTA Watch is a web-based service offering instant access to a global repository of published HTA reports from nearly 100 agencies in 32 countries, providing regularly updated assessments to help inform life sciences and healthcare companies’ strategic decision-making*. In this edition of our HTA uncovered series, we will look specifically at the market access consequences of accelerated access pathways. We'll look at the impact of accelerated regulatory approval on HTA outcomes, using Germany and France as examples. Also, learn more about the growing influence of USA-based HTA body ICER and how its findings compare to international agencies.
White Paper July 06, 2016